Cocrystal Pharma furnishes corporate presentation with no material new disclosures

Cocrystal Pharma, Inc.

Filed an investor presentation on April 23, 2025 under Item 7.01 Regulation FD.
Presentation content not provided; no specific data on pipeline, finances, or milestones.
No material operational, financial, or strategic updates disclosed in the filing.

item 7.01 item 9.01

Cocrystal Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-005876

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.